Skip to main content
Top
Published in: Journal of Inflammation 1/2014

Open Access 01-12-2014 | Research

Effect of remote ischemic post-conditioning on systemic inflammatory response and survival rate in lipopolysaccharide-induced systemic inflammation model

Authors: Yun-Hee Kim, Dae-Wui Yoon, Je-Hyeong Kim, Jeoung-Hyuk Lee, Choon-Hak Lim

Published in: Journal of Inflammation | Issue 1/2014

Login to get access

Abstract

Background

Remote ischemic preconditioning (RIPC) and postconditioning (RpostC) have protective effects on ischemia and reperfusion injury. The effects have been reported to activate heme oxygenase-1 (HO-1) and attenuate nuclear factor kappa B (NF-κB) and subsequently reduce systemic inflammation. Ischemic preconditioning prevented inflammatory responses by modulating HO-1 expression in endotoxic shock model. Therefore, we investigated whether RpostC could have protective effects on lipopolysaccharide (LPS)-induced systemic inflammation.

Methods

The LPS-induced sepsis mice received LPS (20 mg/kg) intraperitoneally. Remote ischemic conditioning was induced with three 10-min ischemia/10-min reperfusion cycles of the right hind limbs using tourniquet before LPS injection (RIPC) or after LPS injection (RpostC). The effects of RIPC and RpostC were examined for the survival rate, serum cytokines, NF-κB, HO-1 and liver pathology in the LPS injected mice.

Results

Survival rate within 120 hours significantly increased in the LPS injected and remote ischemic conditioned mice than in LPS only injected mice (60-65% vs 5%, respectively, p < 0.01). Tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β) and interleukin-6 (IL-6) increased markedly in the LPS only injected mice, however, remote ischemic conditioning suppressed the changes (p < 0.05). Interleukin-10 (IL-10) level was significantly higher in the LPS injected and RpostC treated mice than in the LPS only injected mice (p = 0.014). NF-κB activation was significantly attenuated (p < 0.05) and HO-1 levels were substantially higher in the LPS injected and remote ischemic conditioned mice than in the LPS only injected mice. Neutrophil infiltration was significantly attenuated in the LPS injected and remote ischemic conditioned mice than in the only LPS injected mice (p < 0.05).

Conclusions

RpostC attenuated inflammatory responses and improved survival outcomes of mice with LPS-induced systemic inflammation. The mechanism may be caused by modifying NF-κB mediated expression of cytokines.
Appendix
Available only for authorised users
Literature
2.
go back to reference Dhainaut JF, Marin N, Mignon A, Vinsonneau C: Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med. 2001, 29: S42-S47.PubMedCrossRef Dhainaut JF, Marin N, Mignon A, Vinsonneau C: Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med. 2001, 29: S42-S47.PubMedCrossRef
3.
go back to reference Matuschak GM, Rinaldo JE: Organ interactions in the adult respiratory distress syndrome during sepsis. Role of the liver in host defense. Chest. 1988, 94: 400-406. 10.1378/chest.94.2.400.PubMedCrossRef Matuschak GM, Rinaldo JE: Organ interactions in the adult respiratory distress syndrome during sepsis. Role of the liver in host defense. Chest. 1988, 94: 400-406. 10.1378/chest.94.2.400.PubMedCrossRef
4.
go back to reference Browder W, Ha T, Chuanfu L, Kalbfleisch JH, Ferguson DA, Williams DL: Early activation of pulmonary nuclear factor kappaB and nuclear factor kappaB and nuclear factor interleukin-6 in polymicrobial sepsis. J Trauma. 1999, 46: 590-596. 10.1097/00005373-199904000-00006.PubMedCrossRef Browder W, Ha T, Chuanfu L, Kalbfleisch JH, Ferguson DA, Williams DL: Early activation of pulmonary nuclear factor kappaB and nuclear factor kappaB and nuclear factor interleukin-6 in polymicrobial sepsis. J Trauma. 1999, 46: 590-596. 10.1097/00005373-199904000-00006.PubMedCrossRef
5.
go back to reference Yoshidome H, Kato A, Edwards MJ, Lentsch AB: Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology. 1999, 30: 203-208. 10.1002/hep.510300120.PubMedCrossRef Yoshidome H, Kato A, Edwards MJ, Lentsch AB: Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology. 1999, 30: 203-208. 10.1002/hep.510300120.PubMedCrossRef
6.
go back to reference Gibbs PE, Maines MD: Biliverdin inhibits activation of NF-kappaB. reversal of inhibition by human biliverdin reductase. Int J Cancer. 2007, 121: 2567-2574. 10.1002/ijc.22978.PubMedCrossRef Gibbs PE, Maines MD: Biliverdin inhibits activation of NF-kappaB. reversal of inhibition by human biliverdin reductase. Int J Cancer. 2007, 121: 2567-2574. 10.1002/ijc.22978.PubMedCrossRef
7.
go back to reference Bellezza I, Tucci A, Galli F, Grottelli S, Mierla AL, Pilolli F, Minelli A: Inhibition of NF-κB nuclear translocation via HO-1 activation underlies α-tocopheryl succinate toxicity. J Nutr Biochem. 2012, 23: 1583-1591. 10.1016/j.jnutbio.2011.10.012.PubMedCrossRef Bellezza I, Tucci A, Galli F, Grottelli S, Mierla AL, Pilolli F, Minelli A: Inhibition of NF-κB nuclear translocation via HO-1 activation underlies α-tocopheryl succinate toxicity. J Nutr Biochem. 2012, 23: 1583-1591. 10.1016/j.jnutbio.2011.10.012.PubMedCrossRef
8.
go back to reference Mallick IH, Winslet MC, Seifalian AM: Ischemic preconditioning of small bowel mitigates the late phase of reperfusion injury: heme oxygenase mediates cytoprotection. Am J Surg. 2010, 199: 223-231. 10.1016/j.amjsurg.2009.01.011.PubMedCrossRef Mallick IH, Winslet MC, Seifalian AM: Ischemic preconditioning of small bowel mitigates the late phase of reperfusion injury: heme oxygenase mediates cytoprotection. Am J Surg. 2010, 199: 223-231. 10.1016/j.amjsurg.2009.01.011.PubMedCrossRef
9.
go back to reference Zeynalov E, Shah ZA, Li RC, Dore S: Heme oxygenase 1 is associated with ischemic preconditioning-induced protection against brain ischemia. Neurobiol Dis. 2009, 35: 264-269. 10.1016/j.nbd.2009.05.010.PubMedPubMedCentralCrossRef Zeynalov E, Shah ZA, Li RC, Dore S: Heme oxygenase 1 is associated with ischemic preconditioning-induced protection against brain ischemia. Neurobiol Dis. 2009, 35: 264-269. 10.1016/j.nbd.2009.05.010.PubMedPubMedCentralCrossRef
10.
go back to reference Xu B, Gao X, Xu J, Lei S, Xia ZY, Xu Y, Xia Z: Ischemic postconditioning attenuates lung reperfusion injury and reduces systemic proinflammatory cytokine release via heme oxygenase 1. J Surg Res. 2011, 166: e157-e164. 10.1016/j.jss.2010.11.902.PubMedCrossRef Xu B, Gao X, Xu J, Lei S, Xia ZY, Xu Y, Xia Z: Ischemic postconditioning attenuates lung reperfusion injury and reduces systemic proinflammatory cytokine release via heme oxygenase 1. J Surg Res. 2011, 166: e157-e164. 10.1016/j.jss.2010.11.902.PubMedCrossRef
11.
go back to reference Xia ZY, Gao J, Ancharaz AK, Liu KX, Xia Z, Luo T: Ischaemic post-conditioning protects lung from ischaemia-reperfusion injury by up-regulation of haeme oxygenase-1. Injury. 2010, 41: 510-516. 10.1016/j.injury.2009.03.002.PubMedCrossRef Xia ZY, Gao J, Ancharaz AK, Liu KX, Xia Z, Luo T: Ischaemic post-conditioning protects lung from ischaemia-reperfusion injury by up-regulation of haeme oxygenase-1. Injury. 2010, 41: 510-516. 10.1016/j.injury.2009.03.002.PubMedCrossRef
12.
go back to reference Lai IR, Chang KJ, Chen CF: The mechanism of hepatic heme oxygenase-1 expression by limb remote ischemic preconditioning. Transplantation. 2007, 83: 364-10.1097/01.tp.0000244732.30613.9c.PubMedCrossRef Lai IR, Chang KJ, Chen CF: The mechanism of hepatic heme oxygenase-1 expression by limb remote ischemic preconditioning. Transplantation. 2007, 83: 364-10.1097/01.tp.0000244732.30613.9c.PubMedCrossRef
13.
go back to reference Kanoria S, Seifalian AM, Williams R, Davidson BR: Hind limb remote preconditioning of the liver: a role for nitric oxide and HO-1. Transplantation. 2007, 83: 363-364. 10.1097/01.tp.0000244731.93810.4f.PubMedCrossRef Kanoria S, Seifalian AM, Williams R, Davidson BR: Hind limb remote preconditioning of the liver: a role for nitric oxide and HO-1. Transplantation. 2007, 83: 363-364. 10.1097/01.tp.0000244731.93810.4f.PubMedCrossRef
14.
go back to reference Lai IR, Chang KJ, Chen CF, Tsai HW: Transient limb ischemia induces remote preconditioning in liver among rats: the protective role of heme oxygenase-1. Transplantation. 2006, 81: 1311-1317. 10.1097/01.tp.0000203555.14546.63.PubMedCrossRef Lai IR, Chang KJ, Chen CF, Tsai HW: Transient limb ischemia induces remote preconditioning in liver among rats: the protective role of heme oxygenase-1. Transplantation. 2006, 81: 1311-1317. 10.1097/01.tp.0000203555.14546.63.PubMedCrossRef
15.
go back to reference Tapuria N, Kumar Y, Habib MM, Abu Amara M, Seifalian AM, Davidson BR: Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury–a review. J Surg Res. 2008, 150: 304-330. 10.1016/j.jss.2007.12.747.PubMedCrossRef Tapuria N, Kumar Y, Habib MM, Abu Amara M, Seifalian AM, Davidson BR: Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury–a review. J Surg Res. 2008, 150: 304-330. 10.1016/j.jss.2007.12.747.PubMedCrossRef
16.
go back to reference Loukogeorgakis SP, Williams R, Panagiotidou AT, Kolvekar SK, Donald A, Cole TJ, Yellon DM, Deanfield JE, MacAllister RJ: Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism. Circulation. 2007, 116: 1386-1395. 10.1161/CIRCULATIONAHA.106.653782.PubMedCrossRef Loukogeorgakis SP, Williams R, Panagiotidou AT, Kolvekar SK, Donald A, Cole TJ, Yellon DM, Deanfield JE, MacAllister RJ: Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism. Circulation. 2007, 116: 1386-1395. 10.1161/CIRCULATIONAHA.106.653782.PubMedCrossRef
17.
go back to reference Harkin DW, Barros D’Sa AA, McCallion K, Hoper M, Campbell FC: Ischemic preconditioning before lower limb ischemia-reperfusion protects against acute lung injury. J Vasc Surg. 2002, 35: 1264-1273. 10.1067/mva.2002.121981.PubMedCrossRef Harkin DW, Barros D’Sa AA, McCallion K, Hoper M, Campbell FC: Ischemic preconditioning before lower limb ischemia-reperfusion protects against acute lung injury. J Vasc Surg. 2002, 35: 1264-1273. 10.1067/mva.2002.121981.PubMedCrossRef
18.
go back to reference Tamion F, Richard V, Renet S, Thuillez C: Intestinal preconditioning prevents inflammatory response by modulating heme oxygenase-1 expression in endotoxic shock model. Am J Physiol Gastrointest Liver Physiol. 2007, 293 (6): G1308-G1314. 10.1152/ajpgi.00154.2007.PubMedCrossRef Tamion F, Richard V, Renet S, Thuillez C: Intestinal preconditioning prevents inflammatory response by modulating heme oxygenase-1 expression in endotoxic shock model. Am J Physiol Gastrointest Liver Physiol. 2007, 293 (6): G1308-G1314. 10.1152/ajpgi.00154.2007.PubMedCrossRef
19.
go back to reference Wen T, Wu ZM, Liu Y, Tan YF, Ren F, Wu H: Upregulation of heme oxygenase-1 with hemin prevents D-galactosamine and lipopolysaccharide-induced acute hepatic injury in rats. Toxicology. 2007, 237: 184-193. 10.1016/j.tox.2007.05.014.PubMedCrossRef Wen T, Wu ZM, Liu Y, Tan YF, Ren F, Wu H: Upregulation of heme oxygenase-1 with hemin prevents D-galactosamine and lipopolysaccharide-induced acute hepatic injury in rats. Toxicology. 2007, 237: 184-193. 10.1016/j.tox.2007.05.014.PubMedCrossRef
20.
go back to reference Ando H, Takamura T, Ota T, Nagai Y, Kobayashi K: Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther. 2000, 294: 1043-1046.PubMed Ando H, Takamura T, Ota T, Nagai Y, Kobayashi K: Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther. 2000, 294: 1043-1046.PubMed
21.
go back to reference Yang J, Qu JM, Summah H, Zhang J, Zhu YG, Jiang HN: Protective effects of imipramine in murine endotoxin-induced acute lung injury. Eur J Pharmacol. 2010, 638: 128-133. 10.1016/j.ejphar.2010.04.005.PubMedCrossRef Yang J, Qu JM, Summah H, Zhang J, Zhu YG, Jiang HN: Protective effects of imipramine in murine endotoxin-induced acute lung injury. Eur J Pharmacol. 2010, 638: 128-133. 10.1016/j.ejphar.2010.04.005.PubMedCrossRef
22.
go back to reference Zhong J, Deaciuc IV, Burikhanov R, de Villiers WJ: Lipopolysaccharide-induced liver apoptosis is increased in interleukin-10 knockout mice. Biochim Biophys Acta. 2006, 1762: 468-477. 10.1016/j.bbadis.2005.12.012.PubMedCrossRef Zhong J, Deaciuc IV, Burikhanov R, de Villiers WJ: Lipopolysaccharide-induced liver apoptosis is increased in interleukin-10 knockout mice. Biochim Biophys Acta. 2006, 1762: 468-477. 10.1016/j.bbadis.2005.12.012.PubMedCrossRef
23.
go back to reference Movat HZ, Cybulsky MI, Colditz IG, Chan MK, Dinarello CA: Acute inflammation in gram-negative infection: endotoxin, interleukin 1, tumor necrosis factor, and neutrophils. Fed Proc. 1987, 46: 97-104.PubMed Movat HZ, Cybulsky MI, Colditz IG, Chan MK, Dinarello CA: Acute inflammation in gram-negative infection: endotoxin, interleukin 1, tumor necrosis factor, and neutrophils. Fed Proc. 1987, 46: 97-104.PubMed
24.
go back to reference Ohzato H, Yoshizaki K, Nishimoto N, Ogata A, Tagoh H, Monden M, Gotoh M, Kishimoto T, Mori T: Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery. 1992, 111: 201-209.PubMed Ohzato H, Yoshizaki K, Nishimoto N, Ogata A, Tagoh H, Monden M, Gotoh M, Kishimoto T, Mori T: Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery. 1992, 111: 201-209.PubMed
25.
go back to reference Debets JM, Kampmeijer R, van der Linden MP, Buurman WA, van der Linden CJ: Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med. 1989, 17: 489-494. 10.1097/00003246-198906000-00001.PubMedCrossRef Debets JM, Kampmeijer R, van der Linden MP, Buurman WA, van der Linden CJ: Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med. 1989, 17: 489-494. 10.1097/00003246-198906000-00001.PubMedCrossRef
26.
go back to reference Veres B, Gallyas F, Varbiro G, Berente Z, Osz E, Szekeres G, Szabo C, Sumegi B: Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol. 2003, 65: 1373-1382. 10.1016/S0006-2952(03)00077-7.PubMedCrossRef Veres B, Gallyas F, Varbiro G, Berente Z, Osz E, Szekeres G, Szabo C, Sumegi B: Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol. 2003, 65: 1373-1382. 10.1016/S0006-2952(03)00077-7.PubMedCrossRef
27.
go back to reference Remick DG, Newcomb DE, Bolgos GL, Call DR: Comparison of the mortality and inflammatory response of two models of sepsis : lipopolysaccharide vs. cecal ligation and puncture. Shock. 2000, 13: 110-116. 10.1097/00024382-200013020-00004.PubMedCrossRef Remick DG, Newcomb DE, Bolgos GL, Call DR: Comparison of the mortality and inflammatory response of two models of sepsis : lipopolysaccharide vs. cecal ligation and puncture. Shock. 2000, 13: 110-116. 10.1097/00024382-200013020-00004.PubMedCrossRef
28.
go back to reference Lutz J, Thurmel K, Heemann U: Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation. J Inflamm. 2010, 7: 1476-9255.CrossRef Lutz J, Thurmel K, Heemann U: Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation. J Inflamm. 2010, 7: 1476-9255.CrossRef
29.
go back to reference Abraham E: Nuclear factor-kappaB and its role in sepsis-associated organ failure. J Infect Dis. 2003, 15: S364-S369.CrossRef Abraham E: Nuclear factor-kappaB and its role in sepsis-associated organ failure. J Infect Dis. 2003, 15: S364-S369.CrossRef
30.
go back to reference Roller J, Laschke MW, Scheuer C, Menger MD: Heme oxygenase (HO)-1 protects from lipopolysaccharide (LPS)-mediated liver injury by inhibition of hepatic leukocyte accumulation and improvement of microvascular perfusion. Langenbecks Arch Surg. 2010, 395: 387-394. 10.1007/s00423-010-0603-8.PubMedCrossRef Roller J, Laschke MW, Scheuer C, Menger MD: Heme oxygenase (HO)-1 protects from lipopolysaccharide (LPS)-mediated liver injury by inhibition of hepatic leukocyte accumulation and improvement of microvascular perfusion. Langenbecks Arch Surg. 2010, 395: 387-394. 10.1007/s00423-010-0603-8.PubMedCrossRef
31.
go back to reference Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, Nabel EG: Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med. 2001, 7: 693-698. 10.1038/89068.PubMedCrossRef Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, Nabel EG: Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med. 2001, 7: 693-698. 10.1038/89068.PubMedCrossRef
32.
go back to reference Otterbein LE, Soares MP, Yamashita K, Bach FH: Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003, 24: 449-455. 10.1016/S1471-4906(03)00181-9.PubMedCrossRef Otterbein LE, Soares MP, Yamashita K, Bach FH: Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003, 24: 449-455. 10.1016/S1471-4906(03)00181-9.PubMedCrossRef
33.
go back to reference Menger MD, Rucker M, Vollmar B: Capillary dysfunction in striated muscle ischemia/reperfusion: on the mechanisms of Capillary “No-Reflow”. Shock. 1997, 8: 2-7. 10.1097/00024382-199707000-00002.PubMedCrossRef Menger MD, Rucker M, Vollmar B: Capillary dysfunction in striated muscle ischemia/reperfusion: on the mechanisms of Capillary “No-Reflow”. Shock. 1997, 8: 2-7. 10.1097/00024382-199707000-00002.PubMedCrossRef
34.
go back to reference Wang ZH, Liang YB, Tang H, Chen ZB, Li ZY, Wu JG, Yang Q, Zeng LJ, Hu XC, Ma ZF: Expression and effects of microRNA-155 in the livers of septic mice. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012, 24: 154-157.PubMed Wang ZH, Liang YB, Tang H, Chen ZB, Li ZY, Wu JG, Yang Q, Zeng LJ, Hu XC, Ma ZF: Expression and effects of microRNA-155 in the livers of septic mice. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012, 24: 154-157.PubMed
35.
go back to reference Plasenzotti R, Stoiber B, Posch M, Windberger U: Red blood cell deformability and aggregation behaviour in different animal. Clin Hemorheol Microcirc. 2004, 31: 105-111.PubMed Plasenzotti R, Stoiber B, Posch M, Windberger U: Red blood cell deformability and aggregation behaviour in different animal. Clin Hemorheol Microcirc. 2004, 31: 105-111.PubMed
36.
go back to reference Morrell MR, Micek ST, Kollef MH: The management of severe sepsis and septic shock. Infect Dis Clin North Am. 2009, 23: 485-501. 10.1016/j.idc.2009.04.002.PubMedCrossRef Morrell MR, Micek ST, Kollef MH: The management of severe sepsis and septic shock. Infect Dis Clin North Am. 2009, 23: 485-501. 10.1016/j.idc.2009.04.002.PubMedCrossRef
37.
go back to reference Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002.PubMedCrossRef Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002.PubMedCrossRef
Metadata
Title
Effect of remote ischemic post-conditioning on systemic inflammatory response and survival rate in lipopolysaccharide-induced systemic inflammation model
Authors
Yun-Hee Kim
Dae-Wui Yoon
Je-Hyeong Kim
Jeoung-Hyuk Lee
Choon-Hak Lim
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2014
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-11-16

Other articles of this Issue 1/2014

Journal of Inflammation 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.